66.0502.08% ( -1.400 )
Delay Closed: Nov 18, 16:08:04News
WuXi XDC surges 12% in Hong Kong trading
Market Movers·Niche Consolidation: Hong Kong's Specialty Leaders Forge Growth Paths Amid Fragmentation
Global Report·- Hong Kong-listed specialty leaders are navigating industry challenges through strategic integration, technological upgrades, and core capabilities. - Key market players are actively expanding operations, such as WuXi XDC acquiring Toffs Pharmaceuticals for HKD 2.79 billion, JD Health launching the Zhuoyi 2.0 AI medical product, and FWD Group achieving a 90% year-on-year surge in new business annualized premiums in Hong Kong. - Additional sector activities include Paradigm Intelligent launching PhanthyCloud, Green Tea Group conducting large-scale share repurchases, and CITIC Securities issuing USD 200 million in notes to fund overseas business expansion.WuXi XDC tumbles 8% as innovative drug sector remains under pressure
HK Stock Market Update·WuXi XDC climbs 3% on block trades, Goldman Sachs upgrade
HK Stock Market Update·WuXi XDC falls 4% as innovative drug sector weakens
HK Stock Market Update·WuXi XDC climbs 4% as shares hit record high
HK Stock Market Update·WuXi XDC hits 52-week high as stock rises 2% in Hong Kong trading
HK Stock Market Update·
